AI-generated summary
The authors treated 25 lesions from 12 patients with cutaneous leishmaniasis using a 595-nm pulsed dye laser. Lesions responded after three or four sessions, and the mean Dermatology Life Quality Index score fell from 12.67 to 4.25, a statistically significant improvement. The authors describe the laser as a new modality to consider, and note that larger studies are needed to define its role.
- Participants
- 12
- Who or what was studied
- Patients with cutaneous leishmaniasis, including 12 patients with 25 lesions
- Wavelengths
- 595 nm
- Limits stated in the abstract
- The sample was small and the abstract does not describe a control group, and the authors state that larger-scale studies are needed.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Energy density (fluence)
- 7 J/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Fluence. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.